Study on How Reboxetine and Methylphenidate Affect Fatigue in Healthy Individuals
- Substances:PlaceboReboxetine+1
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:Placebo
- Sponsor:Vrije Universiteit Brussel
Rare diseases
Investigational molecules
Locations
Back to Belgium1 924 clinical trials in Bierbeek, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumStudy Comparing Intradermal and Intramuscular Rabies Vaccination with Inactivated Rabies Virus for Patients Needing a Booster Dose
BelgiumStudy on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition
BelgiumStudy of intranasal lysine-aspirin effectiveness in patients with NSAID-exacerbated respiratory disease (N-ERD)
BelgiumStudy on the Safety and Immune Response of a New Influenza Vaccine with GSKVX000000034794 in Healthy Younger and Older Adults
BelgiumStudy on the Effectiveness and Safety of OVX836 Vaccine for Preventing Influenza in Healthy Adults Aged 18-59
BelgiumStudy on the Safety and Effects of Intranasal EV25 in Healthy Adults with and without Influenza Virus Exposure
BelgiumStudy on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants
BelgiumStudy Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments
BelgiumStudy of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification
BelgiumStudy Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer
BelgiumStudy on the Effects of Remibrutinib for Patients with Generalized Myasthenia Gravis
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical investigations focusing on schizophrenia and cognitive impairment, evaluating long-term safety profiles of innovative therapeutic approaches.
This research builds upon previous clinical trials, specifically examining the continued effectiveness and safety of iclepertin in patients who have completed earlier treatment phases.
Advanced research in psychiatric treatment focusing on developing safer, more effective therapies for individuals with chronic mental health conditions.
The studies aim to enhance understanding of long-term therapeutic outcomes in patients with cognitive impairment related to schizophrenia.
Comprehensive research examining the intersection of cognitive function and mental health conditions, with a focus on therapeutic interventions.
These trials represent continued efforts to improve treatment options for individuals affected by cognitive challenges associated with psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.